Le Jeune Puetz Investment Counsel LLC Myriad Genetics Inc Transaction History

Le Jeune Puetz Investment Counsel LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$11.25 - $14.75 $112,500 - $147,500	-10,000 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$10.69 - $16.49 $20,578 - $31,743	-1,925 Reduced 16.14%	10,000 $113,000
Q1 2020 Apr 29, 2020	SELL	$9.78 - $29.53 $78,240 - $236,240	-8,000 Reduced 40.15%	11,925 $171,000
Q4 2019 Jan 28, 2020	SELL	$20.93 - $35.1 $125,580 - $210,600	-6,000 Reduced 23.14%	19,925 $543,000
Q3 2019 Oct 23, 2019	SELL	$22.08 - $47.08 $15,455 - $32,956	-700 Reduced 2.63%	25,925 $742,000
Q2 2019 Jul 29, 2019	BUY	$22.67 - $35.0 $15,869 - $24,500	700 Added 2.7%	26,625 $740,000
Q1 2019 Apr 23, 2019	BUY	$26.93 - $34.7 $26,930 - $34,700	1,000 Added 4.01%	25,925 $861,000
Q4 2018 Jan 30, 2019	BUY	$27.23 - $45.56 $10,892 - $18,224	400 Added 1.63%	24,925 $725,000
Q2 2018 Jul 26, 2018	SELL	$27.75 - $40.17 $124,875 - $180,765	-4,500 Reduced 15.5%	24,525 $916,000
Q3 2017 Oct 20, 2017	BUY	$24.01 - $36.2 $696,890 - $1.05 Million	29,025	29,025 $1.05 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.